6;9 translocation in myelodysplastic syndrome.

[1]  M. Slovak,et al.  Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. , 1997, American journal of clinical pathology.

[2]  R. Krance,et al.  Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation , 1997, Leukemia.

[3]  H. Mori,et al.  Prognostic implications in myelodysplastic syndromes: A review of 62 cases. , 1996, Leukemia & lymphoma.

[4]  K. Byth,et al.  The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution , 1995, British journal of haematology.

[5]  M. Fornerod,et al.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. , 1995, Oncogene.

[6]  Z. Zemanová,et al.  Karyotype at diagnosis, subsequent leukemic transformation and survival in myelodysplastic syndrome. Czechoslovak MDS Cooperative Group. , 1995, Leukemia research.

[7]  J. M. García-Sagredo,et al.  t(6;9)(p22.3;q34) in a patient with refractory anemia with excess of blasts in transformation. , 1993, Cancer genetics and cytogenetics.

[8]  A. Hagemeijer,et al.  The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features , 1992 .

[9]  A. Hagemeijer,et al.  Dek-can rearrangement in translocation (6;9)(p23;q34). , 1992, Leukemia.

[10]  A. Cuneo,et al.  Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement. , 1989, Cancer genetics and cytogenetics.

[11]  C. Infante-Rivard,et al.  Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes , 1988, American journal of hematology.

[12]  A. Raza,et al.  Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome--refractory anemia with excess blasts. , 1987, Cancer genetics and cytogenetics.

[13]  F. Mitelman,et al.  High resolution banding analysis of the reciprocal translocation t(6;9) in acute nonlymphocytic leukemia. , 1986, Cancer genetics and cytogenetics.

[14]  S. Schwartz,et al.  Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL , 1985, American journal of hematology.

[15]  D. Galton.  The myelodysplastic syndromes. , 1987, Clinical and laboratory haematology.

[16]  J. Yunis,et al.  Recurrent chromosomal defects are found in most patients with acute nonlymphocytic leukemia. , 1984, Cancer genetics and cytogenetics.

[17]  S. Jhanwar,et al.  Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Rowley,et al.  Chromosomal banding patterns in acute nonlymphocytic leukemia. , 1976, Blood.